These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38731813)

  • 1. BMP Stimulation Differentially Affects Phosphorylation and Protein Stability of β-Catenin in Breast Cancer Cell Lines.
    Ilhan M; Hastar N; Kampfrath B; Spierling DN; Jatzlau J; Knaus P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer.
    Clausen KA; Blish KR; Birse CE; Triplette MA; Kute TE; Russell GB; D'Agostino RB; Miller LD; Torti FM; Torti SV
    Breast Cancer Res Treat; 2011 Oct; 129(3):737-46. PubMed ID: 21113658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
    Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
    Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
    Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
    Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
    Pouliot F; Labrie C
    J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin.
    Salazar VS; Zarkadis N; Huang L; Watkins M; Kading J; Bonar S; Norris J; Mbalaviele G; Civitelli R
    J Cell Sci; 2013 Dec; 126(Pt 24):5598-609. PubMed ID: 24101723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of bone morphogenetic protein-6 gene expression in breast cancer cells.
    Zhang M; Wang Q; Yuan W; Yang S; Wang X; Yan JD; Du J; Yin J; Gao SY; Sun BC; Zhu TH
    J Steroid Biochem Mol Biol; 2007; 105(1-5):91-7. PubMed ID: 17574840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts.
    Zhang R; Oyajobi BO; Harris SE; Chen D; Tsao C; Deng HW; Zhao M
    Bone; 2013 Jan; 52(1):145-56. PubMed ID: 23032104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype.
    Salazar VS; Zarkadis N; Huang L; Norris J; Grimston SK; Mbalaviele G; Civitelli R
    J Cell Sci; 2013 Nov; 126(Pt 21):4974-84. PubMed ID: 24006258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2.
    Hussein SM; Duff EK; Sirard C
    J Biol Chem; 2003 Dec; 278(49):48805-14. PubMed ID: 14551209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines.
    Barros R; Pereira B; Duluc I; Azevedo M; Mendes N; Camilo V; Jacobs RJ; Paulo P; Santos-Silva F; van Seuningen I; van den Brink GR; David L; Freund JN; Almeida R
    J Pathol; 2008 Aug; 215(4):411-20. PubMed ID: 18498120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of BMP-2 on the proliferation of breast cancer cells.
    Chen A; Wang D; Liu X; He S; Yu Z; Wang J
    Mol Med Rep; 2012 Sep; 6(3):615-20. PubMed ID: 22735990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
    Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
    Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
    Nakashima A; Katagiri T; Tamura M
    J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of bone morphogenetic protein receptor IA in pancreatic cancer is associated with a poor prognosis.
    Voorneveld PW; Stache V; Jacobs RJ; Smolders E; Sitters AI; Liesker A; Korkmaz KS; Lam SM; De Miranda NF; Morreau H; Kodach LL; Hardwick JC
    Br J Cancer; 2013 Oct; 109(7):1805-12. PubMed ID: 23969729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.